Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep15341.pdf
Reference16 articles.
1. Zhu, Y., Wang, H. K., Qu, Y. Y. & Ye, D. W. Prostate cancer in East Asia: evolving trend over the last decade. Asian journal of andrology 17, 48–57, doi: 10.4103/1008-682X.132780 (2015).
2. Hu, Y. et al. Longitudinal trends in prostate cancer incidence, mortality and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009. BMC public health 14, 356, doi: 10.1186/1471-2458-14-356 (2014).
3. Zhu, Y. et al. Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens. PloS one 10, e0121076, 10.1371/journal.pone.0121076 (2015).
4. Peyromaure, M. et al. Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol 174, 1794–1797, 10.1097/01.ju.0000176817.46279.93 (2005).
5. Ren, S. et al. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. The Prostate . 10.1002/pros.22721 (2013).
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study;The World Journal of Men's Health;2024
2. Development and internal validation of a nomogram predicting significant prostate cancer: Is it clinically applicable in low prevalent prostate cancer countries? A multicenter study;The Prostate;2023-09-27
3. Development and validation of a multi-parameter nomogram for predicting prostate cancer: a retrospective analysis from Handan Central Hospital in China;PeerJ;2022-03-02
4. The research of the application of a new urinary biomarker PCA-M of prostate cancer (PSA from 4 to 20 ng/ml);All Life;2022-02-14
5. Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy;Medicine;2021-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3